Skip to main content
. 2018 Jan 9;9(6):6691–6706. doi: 10.18632/oncotarget.24068

Table 4. Comparison of lymph node pathology between iMCD and IgG4-RD.

iMCD
(n=14)
IgG4-RD
(n=10)
p-value
Findings in iMCD diagnostic criteria (n, %)
 Regressed germinal centers (G2-3) 4 (29%) 1 (10%) 0.358
 Follicular dendritic cell prominence (G2-3) 4 (29%) 3 (30%) 1.000
 Vascularity (G2-3) 11 (79%) 6 (60%) 0.393
 Hyperplastic germinal centers (G2-3) 6 (43%) 8 (80%) 0.104
 Plasmacytosis (G2-3) 12 (86%) 7 (70%) 0.615
 Plasmacytosis (G3) 11 (79%) 0 <0.001
Other findings (n, %)
 Eosinophil infiltration (>10 cells/hpf) 0 4 (40%) 0.020
 Neutrophil infiltration (>10 cells/hpf) 0 0
 Broadened laminated mantle zone 5 (36%) 1 (10%) 0.341
Immunohistochemistry
 IgG4+ plasma cells
  Positive cell count (median, range) 247.5 (4-636) 236 (23-370) 0.953
  >10 cells/hpf (n, %) 13 (93%) 10 (100%) 1.000
  >50 cells/hpf (n, %) 12 (86%) 9 (90%) 1.000
 IgG4+/IgG+ plasma cell ratio
  Ratio (median, range) 36.7 (2.1-71.5) 68.3 (43.6-94.9) 0.002
  >40% (n, %) 5 (36%) 10 (100%) 0.002
  >70% (n, %) 2 (14%) 4 (40%) 0.192

G2, grade 2; G3, grade 3.